Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Blogs
»
Drug Injury Watch: New Reports Of Vytorin And Zetia Causing Liver Failure And Liver Disease
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
3
Vote
Drug Injury Watch: New Reports Of Vytorin And Zetia Causing Liver Failure And Liver Disease
Posted by
tjlpa
91 days ago
(
http://www.drug-injury.com
)
View profile
Category
:
Blogs
|
Tags
:
vytorin
zetia
liver
drug-injury
2008 Medical Journal Articles Describe Two Cases; Authors Suggest Liver Testing At Start Of Therapy And When Titrating Dosage Is Necessary
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
tjlpa
worldpharmanews
G00gle
Related Links
PharmaGossip: Vytorin - PharmaGossip readers have their say
Drug Injury Watch: Does Debate Over Whether Zetia And Vytorin Are, In Fact, Effective Overshadow The Drug-Safety Aspect?
Lawmakers examine Web postings in Vytorin probe
Pharma Chat Board Has Nothing for Congress on Vytorin
Pharmalot » Hassan Comes Clean About Vytorin. Or Did He?
Scientific Misconduct Blog: ENHANCE trial - CEO saw outcome in piece of toast
Pharmalot » From Vytorin To Whytorin? The Enhance Saga
Health Blog: Whither Vytorin? Consider Canada
Princess Zetia and the pea
Pharmalot » Has Vytorin Created New FDA Approval Hurdles?
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
1
Children in the world's poores...
Published News
1
Children in the world's poores...
2
Drug Injury Watch: Risk Of Dig...
1
New discovery: lethal fungus r...
2
UnitedHealth Takes On Microsof...
2
Goodwin: Pharma Ties Have 'Nev...
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
bayer
biotech
drug-injury
drug-safety
fda
glaxosmithkline
novartis
pfizer
pharma
training courses
read more
Comments